Alan D. Snow
61Patents
10h-index
30Co-inventors
78Inventor score
Filing activity: Jun 5, 1995 → Nov 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5958883A | Animal models of human amyloidoses | Human Necessities | 81 | Expired |
| US7285293B2 | Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants | Human Necessities | 48 | Expired |
| US6340783B1 | Rodent models of human amyloidoses | Human Necessities | 38 | Expired |
| US6264994A | Compositions for treating alzheimer's disease and other amyloidoses | Human Necessities | 26 | Expired |
| US6037327A | Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses | Human Necessities | 23 | Expired |
| US7238488B2 | Therapeutic and diagnostic applications of perlecan domain I splice variants | Chemistry; Metallurgy | 21 | Expired |
| US6939570B1 | Composition and methods for treating Alzheimer's disease and other amyloidoses | Human Necessities | 18 | Expired |
| US7763747B2 | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease | Chemistry; Metallurgy | 15 | Active |
| US6346280B1 | Composition and methods for inhibiting the formation of brain amyloid deposits | Human Necessities | 12 | Expired |
| US6607758B2 | Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses | Human Necessities | 11 | Expired |
| US6933280B2 | Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | Human Necessities | 10 | Expired |
| US7514583B2 | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease | Chemistry; Metallurgy | 10 | Expired |
| US6432636B1 | Diagnostic applications of perlecan domain I splice variants | Physics | 7 | Expired |
| US7601876B2 | Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis | Chemistry; Metallurgy | 4 | Active |
| US7714170B2 | Use of compounds and compositions for the treatment of amyloid diseases | Chemistry; Metallurgy | 4 | Active |
| US8455687B2 | Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies | Chemistry; Metallurgy | 4 | Active |
| US7314642B2 | Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants | Human Necessities | 4 | Expired |
| US7148001B2 | In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases | Human Necessities | 4 | Expired |
| US6563016B1 | Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses | Chemistry; Metallurgy | 3 | Expired |
| US7384910B2 | Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | Physics | 3 | Expired |
| US6929808B2 | Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants | Human Necessities | 3 | Expired |
| US7276483B1 | Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | Human Necessities | 2 | Expired |
| US10350258B2 | Compositions and methods for the treatment of plaques and tangles in humans and animals | Human Necessities | 2 | Active |
| US7208475B2 | Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | Human Necessities | 2 | Expired |
| US7314724B2 | Therapeutic applications of laminin and laminin-derived protein fragments | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.